Novartis pharma head leaves as drug maker splits operations #helvoet #pharma

Posted On Nov 8 2017 by

#novartis pharma # Novartis pharma head leaves as drug maker splits operations Underscoring its increasing emphasis on oncology, Novartis is splitting its prescription drug business into two organizations and hired Paul Hudson, who heads North American operations for AstraZeneca, to lead the pharmaceutical business. The newly created oncology unit, meanwhile, will be run by Bruno Strigini, who already runs the cancer-drug business. The move comes a year after Novartis purchased a portfolio of oncology medicines from GlaxoSmithKline as part of an asset swap. But Novartis is also contending with declining sales of its Gleevec cancer medicine, which has been a …


In Guilty Plea, OxyContin Maker to Pay $600 Million #medicinal #chemistry

Posted On Sep 24 2017 by

#purdue pharmaceutical # The New York Times In Guilty Plea, OxyContin Maker to Pay $600 Million From left, Howard R. Udell, the top lawyer for Purdue Pharma; Dr. Paul D. Goldenheim, the company s former medical director; and Michael Friedman, Purdue s president. Photographs by Don Petersen for The New York Times May 10, 2007 ABINGDON, Va. May 10 — The company that makes the narcotic painkiller OxyContin and three current and former executives pleaded guilty today in federal court here to criminal charges that they misled regulators, doctors and patients about the drug’s risk of addiction and its potential …


Free Website Builder – Easiest website builder for your website #website #builder, #web #site #builder, #web #builder, #create #a #website, #build #a #website, #easy #website #creator, #easy #website #builder, #best #website #builder, #website #maker, #free #website #builder, #free #website #maker, #search #engine #friendly, #search #engine #optimized #pages

Posted On Aug 28 2017 by

# Ewisoft Website Builder is a powerful and easy website builder software that you can use to create a website. It is perfect for beginners and professionals. It is so easy to use, all you have to do to start a website is edit text, insert images, and drag-and-drop. You get amazing results when your website is built and maintained by Ewisoft Website Builder. Download and try it now and you will see how easy it is to build your website in only a few minutes. eCommerce Website Builder to sell products online. The eCommerce website builder software is an …


Blue Leaf Book Scanning Service #book #scanning, #book #scanning #service, #book #scan #service, #convert #books #to #audiobook, #audiobook #builder, #audiobook #creator, #audiobook #maker #service, #document #scanning #service, #digitize #books, #book #to #pdf, #how #to #scan #books

Posted On Aug 23 2017 by

# ONDEMAND Book Scanning Service Blue Leaf now makes book scanning affordable for the everyday consumer and small business. Our non-destructive scanning process converts virtually any size book or document to any file format, including searchable PDF, eBook (Kindle, Nook, Sony. ), audiobook (mp3), and editable text-based formats such as Word, RTF, and TXT. Our service is ideal for Log Books Textbooks Drawings Technical Documents Digitizing Valuable Books or Documents Publishing Manuals For Customer Base Republishing Out-Of-Print Books eBook Creation (Kindle, Nook, iPad, etc.) Audiobook Creation. Sample Instant Search and Indexing *please read FAQ for more information. Customer Testimonials! 3 …


Novartis pharma head leaves as drug maker splits operations #lexicon #pharma

Posted On May 18 2017 by

#novartis pharma # Novartis pharma head leaves as drug maker splits operations Underscoring its increasing emphasis on oncology, Novartis is splitting its prescription drug business into two organizations and hired Paul Hudson, who heads North American operations for AstraZeneca, to lead the pharmaceutical business. The newly created oncology unit, meanwhile, will be run by Bruno Strigini, who already runs the cancer-drug business. The move comes a year after Novartis purchased a portfolio of oncology medicines from GlaxoSmithKline as part of an asset swap. But Novartis is also contending with declining sales of its Gleevec cancer medicine, which has been a …


Novartis pharma head leaves as drug maker splits operations #small #pharma #companies

Posted On Apr 22 2017 by

#novartis pharma # Novartis pharma head leaves as drug maker splits operations Underscoring its increasing emphasis on oncology, Novartis is splitting its prescription drug business into two organizations and hired Paul Hudson, who heads North American operations for AstraZeneca, to lead the pharmaceutical business. The newly created oncology unit, meanwhile, will be run by Bruno Strigini, who already runs the cancer-drug business. The move comes a year after Novartis purchased a portfolio of oncology medicines from GlaxoSmithKline as part of an asset swap. But Novartis is also contending with declining sales of its Gleevec cancer medicine, which has been a …


Novartis pharma head leaves as drug maker splits operations #cafe #pharma #novartis

Posted On Apr 5 2017 by

#novartis pharma # Novartis pharma head leaves as drug maker splits operations Underscoring its increasing emphasis on oncology, Novartis is splitting its prescription drug business into two organizations and hired Paul Hudson, who heads North American operations for AstraZeneca, to lead the pharmaceutical business. The newly created oncology unit, meanwhile, will be run by Bruno Strigini, who already runs the cancer-drug business. The move comes a year after Novartis purchased a portfolio of oncology medicines from GlaxoSmithKline as part of an asset swap. But Novartis is also contending with declining sales of its Gleevec cancer medicine, which has been a …


Novartis pharma head leaves as drug maker splits operations #elixir #pharma

Posted On Mar 24 2017 by

#novartis pharma # Novartis pharma head leaves as drug maker splits operations Underscoring its increasing emphasis on oncology, Novartis is splitting its prescription drug business into two organizations and hired Paul Hudson, who heads North American operations for AstraZeneca, to lead the pharmaceutical business. The newly created oncology unit, meanwhile, will be run by Bruno Strigini, who already runs the cancer-drug business. The move comes a year after Novartis purchased a portfolio of oncology medicines from GlaxoSmithKline as part of an asset swap. But Novartis is also contending with declining sales of its Gleevec cancer medicine, which has been a …


In Guilty Plea, OxyContin Maker to Pay $600 Million #martindale #pharma

Posted On Mar 14 2017 by

#purdue pharmaceutical # The New York Times In Guilty Plea, OxyContin Maker to Pay $600 Million From left, Howard R. Udell, the top lawyer for Purdue Pharma; Dr. Paul D. Goldenheim, the company s former medical director; and Michael Friedman, Purdue s president. Photographs by Don Petersen for The New York Times May 10, 2007 ABINGDON, Va. May 10 — The company that makes the narcotic painkiller OxyContin and three current and former executives pleaded guilty today in federal court here to criminal charges that they misled regulators, doctors and patients about the drug’s risk of addiction and its potential …


Novartis pharma head leaves as drug maker splits operations #jrs #pharma

Posted On Feb 5 2017 by

#novartis pharma # Novartis pharma head leaves as drug maker splits operations Underscoring its increasing emphasis on oncology, Novartis is splitting its prescription drug business into two organizations and hired Paul Hudson, who heads North American operations for AstraZeneca, to lead the pharmaceutical business. The newly created oncology unit, meanwhile, will be run by Bruno Strigini, who already runs the cancer-drug business. The move comes a year after Novartis purchased a portfolio of oncology medicines from GlaxoSmithKline as part of an asset swap. But Novartis is also contending with declining sales of its Gleevec cancer medicine, which has been a …